DNA methylation epi-signature and biological age in attention deficit hyperactivity disorder patients

Attention Deficit/Hyperactivity Disorder (ADHD) is a common behavioral syndrome that begins in childhood and affects 3.4% of children worldwide. Due to its etiological complexity, there are no consistent biomarkers for ADHD, however the high heritability presented by the disorder indicates a genetic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical neurology and neurosurgery 2023-05, Vol.228, p.107714-107714, Article 107714
Hauptverfasser: Carvalho, Gleyson Francisco da Silva, Costa, Thais Virginia Moura Machado, Nascimento, Amom Mendes, Wolff, Beatriz Martins, Damasceno, Julian Gabriel, Vieira, Lucas Liro, Almeida, Vanessa Tavares, Oliveira, Yanca Gasparini de, Mello, Claudia Berlim de, Muszkat, Mauro, Kulikowski, Leslie Domenici
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 107714
container_issue
container_start_page 107714
container_title Clinical neurology and neurosurgery
container_volume 228
creator Carvalho, Gleyson Francisco da Silva
Costa, Thais Virginia Moura Machado
Nascimento, Amom Mendes
Wolff, Beatriz Martins
Damasceno, Julian Gabriel
Vieira, Lucas Liro
Almeida, Vanessa Tavares
Oliveira, Yanca Gasparini de
Mello, Claudia Berlim de
Muszkat, Mauro
Kulikowski, Leslie Domenici
description Attention Deficit/Hyperactivity Disorder (ADHD) is a common behavioral syndrome that begins in childhood and affects 3.4% of children worldwide. Due to its etiological complexity, there are no consistent biomarkers for ADHD, however the high heritability presented by the disorder indicates a genetic/epigenetic influence. The main epigenetic mechanism is DNA methylation, a process with an important role in gene expression and in many psychiatric disorders. Thus, our study sought to identify epi-signatures biomarkers in 29 children clinically diagnosed with ADHD. After DNA extraction and bisulfite conversion, we performed methylation array experiment for differential methylation, ontological and biological age analysis. The biological response in ADHD patients was not sufficient to determine a conclusive epi-signature in our study. However, our results highlighted the interaction of energy metabolism and oxidative stress pathways in ADHD patients detected by differential methylation patterns. Furthermore, we were able to identify a marginal association between the DNAmAge and ADHD. Our study present new methylation biomarkers findings associated with energy metabolism and oxidative stress pathways, in addition to DNAmAge in ADHD patients. However, we propose that further multiethnic studies, with larger cohorts and including maternal conditions, are necessary to demonstrate a definitive association between ADHD and these methylation biomarkers. •There is still no conclusive episignature for ADHD.•Oxidative stress and energy metabolism play a crucial role in the pathophysiology of ADHD.•Biological methylation age (DNAmAge) acceleration has a marginal association with clinical status of ADHD.
doi_str_mv 10.1016/j.clineuro.2023.107714
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2801984633</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0303846723001300</els_id><sourcerecordid>2801984633</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-401e184aa266785f050391d69f7d45b822817c6254ce059127cbb0febd8c01313</originalsourceid><addsrcrecordid>eNqFkU9P3DAQxa2qVVlovwKy1EsvWfwvtnMDQVuQUHspZ8uxJ4tX2TjYDtJ--3pZ6KGXnkYa_d6b0XsInVOypoTKi-3ajWGCJcU1I4zXpVJUvEMrqhVrZCf1e7QinPBGC6lO0GnOW0II51J_RCdckVYIJVcIbn5e4R2Ux_1oS4gThjk0OWwmW5YE2E4e9yGOcROcHbHdAA4TtqXA9EJ7GIILBT_uZ0jWlfAcyh77kGPykPBcPSuZP6EPgx0zfH6dZ-jh-7ff17fN_a8fd9dX943jnSyNIBSoFtYyKZVuB9IS3lEvu0F50faaMU2Vk6wVDkjbUaZc35MBeq8doZzyM_T16Dun-LRALmYXsoNxtBPEJRumCe1qIJxX9Ms_6DYuaarfHShxuNS1lZJHyqWYc4LBzCnsbNobSsyhCLM1b0WYQxHmWEQVnr_aL_0O_F_ZW_IVuDwCUPN4DpBMdjUrBz4kcMX4GP534w_ZQ5z7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2804281795</pqid></control><display><type>article</type><title>DNA methylation epi-signature and biological age in attention deficit hyperactivity disorder patients</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Carvalho, Gleyson Francisco da Silva ; Costa, Thais Virginia Moura Machado ; Nascimento, Amom Mendes ; Wolff, Beatriz Martins ; Damasceno, Julian Gabriel ; Vieira, Lucas Liro ; Almeida, Vanessa Tavares ; Oliveira, Yanca Gasparini de ; Mello, Claudia Berlim de ; Muszkat, Mauro ; Kulikowski, Leslie Domenici</creator><creatorcontrib>Carvalho, Gleyson Francisco da Silva ; Costa, Thais Virginia Moura Machado ; Nascimento, Amom Mendes ; Wolff, Beatriz Martins ; Damasceno, Julian Gabriel ; Vieira, Lucas Liro ; Almeida, Vanessa Tavares ; Oliveira, Yanca Gasparini de ; Mello, Claudia Berlim de ; Muszkat, Mauro ; Kulikowski, Leslie Domenici</creatorcontrib><description>Attention Deficit/Hyperactivity Disorder (ADHD) is a common behavioral syndrome that begins in childhood and affects 3.4% of children worldwide. Due to its etiological complexity, there are no consistent biomarkers for ADHD, however the high heritability presented by the disorder indicates a genetic/epigenetic influence. The main epigenetic mechanism is DNA methylation, a process with an important role in gene expression and in many psychiatric disorders. Thus, our study sought to identify epi-signatures biomarkers in 29 children clinically diagnosed with ADHD. After DNA extraction and bisulfite conversion, we performed methylation array experiment for differential methylation, ontological and biological age analysis. The biological response in ADHD patients was not sufficient to determine a conclusive epi-signature in our study. However, our results highlighted the interaction of energy metabolism and oxidative stress pathways in ADHD patients detected by differential methylation patterns. Furthermore, we were able to identify a marginal association between the DNAmAge and ADHD. Our study present new methylation biomarkers findings associated with energy metabolism and oxidative stress pathways, in addition to DNAmAge in ADHD patients. However, we propose that further multiethnic studies, with larger cohorts and including maternal conditions, are necessary to demonstrate a definitive association between ADHD and these methylation biomarkers. •There is still no conclusive episignature for ADHD.•Oxidative stress and energy metabolism play a crucial role in the pathophysiology of ADHD.•Biological methylation age (DNAmAge) acceleration has a marginal association with clinical status of ADHD.</description><identifier>ISSN: 0303-8467</identifier><identifier>EISSN: 1872-6968</identifier><identifier>DOI: 10.1016/j.clineuro.2023.107714</identifier><identifier>PMID: 37054476</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>ADHD ; Age ; Aging ; Attention Deficit Disorder with Hyperactivity - genetics ; Attention Deficit Disorder with Hyperactivity - metabolism ; Attention deficit hyperactivity disorder ; Biomarkers ; Biomarkers - metabolism ; Bisulfite ; Blood ; Cancer ; Child ; Children ; DNA methylation ; DNA Methylation - genetics ; DNAmAge ; Energy metabolism ; Epi-signature ; Epigenesis, Genetic ; Epigenetic ; Epigenetics ; Etiology ; Gene expression ; Genes ; Genetic testing ; Heritability ; Humans ; Hyperactivity ; Kruskal-Wallis test ; Mental disorders ; Metabolism ; Methylation ; Nervous system ; Neurology ; Ontology ; Oxidative metabolism ; Oxidative stress</subject><ispartof>Clinical neurology and neurosurgery, 2023-05, Vol.228, p.107714-107714, Article 107714</ispartof><rights>2023 Elsevier B.V.</rights><rights>Copyright © 2023 Elsevier B.V. All rights reserved.</rights><rights>2023. Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-401e184aa266785f050391d69f7d45b822817c6254ce059127cbb0febd8c01313</citedby><cites>FETCH-LOGICAL-c396t-401e184aa266785f050391d69f7d45b822817c6254ce059127cbb0febd8c01313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0303846723001300$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37054476$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carvalho, Gleyson Francisco da Silva</creatorcontrib><creatorcontrib>Costa, Thais Virginia Moura Machado</creatorcontrib><creatorcontrib>Nascimento, Amom Mendes</creatorcontrib><creatorcontrib>Wolff, Beatriz Martins</creatorcontrib><creatorcontrib>Damasceno, Julian Gabriel</creatorcontrib><creatorcontrib>Vieira, Lucas Liro</creatorcontrib><creatorcontrib>Almeida, Vanessa Tavares</creatorcontrib><creatorcontrib>Oliveira, Yanca Gasparini de</creatorcontrib><creatorcontrib>Mello, Claudia Berlim de</creatorcontrib><creatorcontrib>Muszkat, Mauro</creatorcontrib><creatorcontrib>Kulikowski, Leslie Domenici</creatorcontrib><title>DNA methylation epi-signature and biological age in attention deficit hyperactivity disorder patients</title><title>Clinical neurology and neurosurgery</title><addtitle>Clin Neurol Neurosurg</addtitle><description>Attention Deficit/Hyperactivity Disorder (ADHD) is a common behavioral syndrome that begins in childhood and affects 3.4% of children worldwide. Due to its etiological complexity, there are no consistent biomarkers for ADHD, however the high heritability presented by the disorder indicates a genetic/epigenetic influence. The main epigenetic mechanism is DNA methylation, a process with an important role in gene expression and in many psychiatric disorders. Thus, our study sought to identify epi-signatures biomarkers in 29 children clinically diagnosed with ADHD. After DNA extraction and bisulfite conversion, we performed methylation array experiment for differential methylation, ontological and biological age analysis. The biological response in ADHD patients was not sufficient to determine a conclusive epi-signature in our study. However, our results highlighted the interaction of energy metabolism and oxidative stress pathways in ADHD patients detected by differential methylation patterns. Furthermore, we were able to identify a marginal association between the DNAmAge and ADHD. Our study present new methylation biomarkers findings associated with energy metabolism and oxidative stress pathways, in addition to DNAmAge in ADHD patients. However, we propose that further multiethnic studies, with larger cohorts and including maternal conditions, are necessary to demonstrate a definitive association between ADHD and these methylation biomarkers. •There is still no conclusive episignature for ADHD.•Oxidative stress and energy metabolism play a crucial role in the pathophysiology of ADHD.•Biological methylation age (DNAmAge) acceleration has a marginal association with clinical status of ADHD.</description><subject>ADHD</subject><subject>Age</subject><subject>Aging</subject><subject>Attention Deficit Disorder with Hyperactivity - genetics</subject><subject>Attention Deficit Disorder with Hyperactivity - metabolism</subject><subject>Attention deficit hyperactivity disorder</subject><subject>Biomarkers</subject><subject>Biomarkers - metabolism</subject><subject>Bisulfite</subject><subject>Blood</subject><subject>Cancer</subject><subject>Child</subject><subject>Children</subject><subject>DNA methylation</subject><subject>DNA Methylation - genetics</subject><subject>DNAmAge</subject><subject>Energy metabolism</subject><subject>Epi-signature</subject><subject>Epigenesis, Genetic</subject><subject>Epigenetic</subject><subject>Epigenetics</subject><subject>Etiology</subject><subject>Gene expression</subject><subject>Genes</subject><subject>Genetic testing</subject><subject>Heritability</subject><subject>Humans</subject><subject>Hyperactivity</subject><subject>Kruskal-Wallis test</subject><subject>Mental disorders</subject><subject>Metabolism</subject><subject>Methylation</subject><subject>Nervous system</subject><subject>Neurology</subject><subject>Ontology</subject><subject>Oxidative metabolism</subject><subject>Oxidative stress</subject><issn>0303-8467</issn><issn>1872-6968</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkU9P3DAQxa2qVVlovwKy1EsvWfwvtnMDQVuQUHspZ8uxJ4tX2TjYDtJ--3pZ6KGXnkYa_d6b0XsInVOypoTKi-3ajWGCJcU1I4zXpVJUvEMrqhVrZCf1e7QinPBGC6lO0GnOW0II51J_RCdckVYIJVcIbn5e4R2Ux_1oS4gThjk0OWwmW5YE2E4e9yGOcROcHbHdAA4TtqXA9EJ7GIILBT_uZ0jWlfAcyh77kGPykPBcPSuZP6EPgx0zfH6dZ-jh-7ff17fN_a8fd9dX943jnSyNIBSoFtYyKZVuB9IS3lEvu0F50faaMU2Vk6wVDkjbUaZc35MBeq8doZzyM_T16Dun-LRALmYXsoNxtBPEJRumCe1qIJxX9Ms_6DYuaarfHShxuNS1lZJHyqWYc4LBzCnsbNobSsyhCLM1b0WYQxHmWEQVnr_aL_0O_F_ZW_IVuDwCUPN4DpBMdjUrBz4kcMX4GP534w_ZQ5z7</recordid><startdate>202305</startdate><enddate>202305</enddate><creator>Carvalho, Gleyson Francisco da Silva</creator><creator>Costa, Thais Virginia Moura Machado</creator><creator>Nascimento, Amom Mendes</creator><creator>Wolff, Beatriz Martins</creator><creator>Damasceno, Julian Gabriel</creator><creator>Vieira, Lucas Liro</creator><creator>Almeida, Vanessa Tavares</creator><creator>Oliveira, Yanca Gasparini de</creator><creator>Mello, Claudia Berlim de</creator><creator>Muszkat, Mauro</creator><creator>Kulikowski, Leslie Domenici</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>202305</creationdate><title>DNA methylation epi-signature and biological age in attention deficit hyperactivity disorder patients</title><author>Carvalho, Gleyson Francisco da Silva ; Costa, Thais Virginia Moura Machado ; Nascimento, Amom Mendes ; Wolff, Beatriz Martins ; Damasceno, Julian Gabriel ; Vieira, Lucas Liro ; Almeida, Vanessa Tavares ; Oliveira, Yanca Gasparini de ; Mello, Claudia Berlim de ; Muszkat, Mauro ; Kulikowski, Leslie Domenici</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-401e184aa266785f050391d69f7d45b822817c6254ce059127cbb0febd8c01313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>ADHD</topic><topic>Age</topic><topic>Aging</topic><topic>Attention Deficit Disorder with Hyperactivity - genetics</topic><topic>Attention Deficit Disorder with Hyperactivity - metabolism</topic><topic>Attention deficit hyperactivity disorder</topic><topic>Biomarkers</topic><topic>Biomarkers - metabolism</topic><topic>Bisulfite</topic><topic>Blood</topic><topic>Cancer</topic><topic>Child</topic><topic>Children</topic><topic>DNA methylation</topic><topic>DNA Methylation - genetics</topic><topic>DNAmAge</topic><topic>Energy metabolism</topic><topic>Epi-signature</topic><topic>Epigenesis, Genetic</topic><topic>Epigenetic</topic><topic>Epigenetics</topic><topic>Etiology</topic><topic>Gene expression</topic><topic>Genes</topic><topic>Genetic testing</topic><topic>Heritability</topic><topic>Humans</topic><topic>Hyperactivity</topic><topic>Kruskal-Wallis test</topic><topic>Mental disorders</topic><topic>Metabolism</topic><topic>Methylation</topic><topic>Nervous system</topic><topic>Neurology</topic><topic>Ontology</topic><topic>Oxidative metabolism</topic><topic>Oxidative stress</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carvalho, Gleyson Francisco da Silva</creatorcontrib><creatorcontrib>Costa, Thais Virginia Moura Machado</creatorcontrib><creatorcontrib>Nascimento, Amom Mendes</creatorcontrib><creatorcontrib>Wolff, Beatriz Martins</creatorcontrib><creatorcontrib>Damasceno, Julian Gabriel</creatorcontrib><creatorcontrib>Vieira, Lucas Liro</creatorcontrib><creatorcontrib>Almeida, Vanessa Tavares</creatorcontrib><creatorcontrib>Oliveira, Yanca Gasparini de</creatorcontrib><creatorcontrib>Mello, Claudia Berlim de</creatorcontrib><creatorcontrib>Muszkat, Mauro</creatorcontrib><creatorcontrib>Kulikowski, Leslie Domenici</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical neurology and neurosurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carvalho, Gleyson Francisco da Silva</au><au>Costa, Thais Virginia Moura Machado</au><au>Nascimento, Amom Mendes</au><au>Wolff, Beatriz Martins</au><au>Damasceno, Julian Gabriel</au><au>Vieira, Lucas Liro</au><au>Almeida, Vanessa Tavares</au><au>Oliveira, Yanca Gasparini de</au><au>Mello, Claudia Berlim de</au><au>Muszkat, Mauro</au><au>Kulikowski, Leslie Domenici</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DNA methylation epi-signature and biological age in attention deficit hyperactivity disorder patients</atitle><jtitle>Clinical neurology and neurosurgery</jtitle><addtitle>Clin Neurol Neurosurg</addtitle><date>2023-05</date><risdate>2023</risdate><volume>228</volume><spage>107714</spage><epage>107714</epage><pages>107714-107714</pages><artnum>107714</artnum><issn>0303-8467</issn><eissn>1872-6968</eissn><abstract>Attention Deficit/Hyperactivity Disorder (ADHD) is a common behavioral syndrome that begins in childhood and affects 3.4% of children worldwide. Due to its etiological complexity, there are no consistent biomarkers for ADHD, however the high heritability presented by the disorder indicates a genetic/epigenetic influence. The main epigenetic mechanism is DNA methylation, a process with an important role in gene expression and in many psychiatric disorders. Thus, our study sought to identify epi-signatures biomarkers in 29 children clinically diagnosed with ADHD. After DNA extraction and bisulfite conversion, we performed methylation array experiment for differential methylation, ontological and biological age analysis. The biological response in ADHD patients was not sufficient to determine a conclusive epi-signature in our study. However, our results highlighted the interaction of energy metabolism and oxidative stress pathways in ADHD patients detected by differential methylation patterns. Furthermore, we were able to identify a marginal association between the DNAmAge and ADHD. Our study present new methylation biomarkers findings associated with energy metabolism and oxidative stress pathways, in addition to DNAmAge in ADHD patients. However, we propose that further multiethnic studies, with larger cohorts and including maternal conditions, are necessary to demonstrate a definitive association between ADHD and these methylation biomarkers. •There is still no conclusive episignature for ADHD.•Oxidative stress and energy metabolism play a crucial role in the pathophysiology of ADHD.•Biological methylation age (DNAmAge) acceleration has a marginal association with clinical status of ADHD.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>37054476</pmid><doi>10.1016/j.clineuro.2023.107714</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0303-8467
ispartof Clinical neurology and neurosurgery, 2023-05, Vol.228, p.107714-107714, Article 107714
issn 0303-8467
1872-6968
language eng
recordid cdi_proquest_miscellaneous_2801984633
source MEDLINE; Elsevier ScienceDirect Journals
subjects ADHD
Age
Aging
Attention Deficit Disorder with Hyperactivity - genetics
Attention Deficit Disorder with Hyperactivity - metabolism
Attention deficit hyperactivity disorder
Biomarkers
Biomarkers - metabolism
Bisulfite
Blood
Cancer
Child
Children
DNA methylation
DNA Methylation - genetics
DNAmAge
Energy metabolism
Epi-signature
Epigenesis, Genetic
Epigenetic
Epigenetics
Etiology
Gene expression
Genes
Genetic testing
Heritability
Humans
Hyperactivity
Kruskal-Wallis test
Mental disorders
Metabolism
Methylation
Nervous system
Neurology
Ontology
Oxidative metabolism
Oxidative stress
title DNA methylation epi-signature and biological age in attention deficit hyperactivity disorder patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T13%3A19%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DNA%20methylation%20epi-signature%20and%20biological%20age%20in%20attention%20deficit%20hyperactivity%20disorder%20patients&rft.jtitle=Clinical%20neurology%20and%20neurosurgery&rft.au=Carvalho,%20Gleyson%20Francisco%20da%20Silva&rft.date=2023-05&rft.volume=228&rft.spage=107714&rft.epage=107714&rft.pages=107714-107714&rft.artnum=107714&rft.issn=0303-8467&rft.eissn=1872-6968&rft_id=info:doi/10.1016/j.clineuro.2023.107714&rft_dat=%3Cproquest_cross%3E2801984633%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2804281795&rft_id=info:pmid/37054476&rft_els_id=S0303846723001300&rfr_iscdi=true